Oppenheimer Reiterates Outperform Rating on Rhythm Pharmaceuticals (RYTM)
Go back to Oppenheimer Reiterates Outperform Rating on Rhythm Pharmaceuticals (RYTM)| (NASDAQ: RYTM) | Delayed: 104.14 +1.94 (1.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.20 | 52 Week High | $ | |||
| Open | $102.96 | 52 Week Low | $ | |||
| Day High | $104.86 | P/E | N/A | |||
| Day Low | $102.25 | EPS | $ | |||
| Volume | 48,165 | |||||
